Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Mirati Therapeutics, Inc. (MRTX)

« Back to company index

MRTX Chatter Timeline

Stock Ticker for MRTX

Most Active Tweeters for MRTX

UserTweets
@ThisLincolnian 7
@ZolmaxNews 6
@dailypoliticaln 6
@AmericanBanking 5
@stocknewstimes 5

Recent Tweets for MRTX

LuciusJameson @LuciusJameson
@SPX219 Just saying mrtx849, Mirati’s G12C inhibitor made by Arry, is next to read-out. $Mrtx will likely be acquir… https://t.co/3GCcq7f495
October 21st 2019, 6:10pm
SwingTradeBot @SwingTradeBot
$MRTX technical alerts: Fell Below 20 DMA, Fell Below 50 DMA, Fell Below 200 DMA, Wide Range Bar,... https://t.co/nJxFc29hIV
October 21st 2019, 8:10am
WeekHerald @WeekHerald
Mirati Therapeutics’ $MRTX Buy Rating Reiterated at Cowen https://t.co/bAPSXuUuiM
October 21st 2019, 1:10am
ThisLincolnian @ThisLincolnian
Cowen Reiterates Buy Rating for Mirati Therapeutics $MRTX https://t.co/fCQNr0wjlY
October 21st 2019, 1:10am
tranbryannguyen @tranbryannguyen
RT @semodough: JEFF $AMGN going to trade on KRAS and hitting #s next driver $MRTX kras data remarkable how MRTX is trading recently on thi…
October 20th 2019, 10:10pm
bbnsnews @bbnsnews
Mirati Therapeutics’ $MRTX Buy Rating Reaffirmed at Cowen https://t.co/4r79JqOjCg
October 20th 2019, 10:10pm
dispatchtribune @dispatchtribune
Mirati Therapeutics $MRTX Stock Rating Reaffirmed by Cowen https://t.co/abVcOKL22r
October 20th 2019, 10:10pm
registrarjourn @registrarjourn
Mirati Therapeutics’ $MRTX “Buy” Rating Reaffirmed at Cowen https://t.co/zgqfhjBxlE
October 20th 2019, 10:10pm
EnterpriseLeade @EnterpriseLeade
Mirati Therapeutics’ $MRTX “Buy” Rating Reaffirmed at Cowen https://t.co/a5RyElolyW
October 20th 2019, 10:10pm
AmericanBanking @AmericanBanking
Mirati Therapeutics $MRTX Given Buy Rating at Cowen https://t.co/fGx4DHxvpE #stocks
October 20th 2019, 9:10pm
semodough @semodough
JEFF $AMGN going to trade on KRAS and hitting #s next driver $MRTX kras data remarkable how MRTX is trading recent… https://t.co/faSEJKOlc5
October 20th 2019, 9:10pm
WatchlistN @WatchlistN
Mirati Therapeutics $MRTX Stock Rating Reaffirmed by Cowen https://t.co/JJiZOKMlwT
October 20th 2019, 9:10pm
IRAMarketReport @IRAMarketReport
Mirati Therapeutics $MRTX Stock Rating Reaffirmed by Cowen https://t.co/2PToHCabHV #markets
October 20th 2019, 9:10pm
chaffeybreeze @chaffeybreeze
Mirati Therapeutics $MRTX Stock Rating Reaffirmed by Cowen https://t.co/raTZtf3vDE #stocks
October 20th 2019, 9:10pm
IcemanTrading @IcemanTrading
$MRTX Huge sellers into every upside push. Shorts in control as it approaches a bigger bear flag. #ICEMAN https://t.co/VhOee2eQtz
October 20th 2019, 6:10pm
gcassidy718 @gcassidy718
$MRTX considerable price movement -12.29 % change recently https://t.co/yyGCIG9Q8V
October 20th 2019, 4:10pm
MarketChmln @MarketChmln
$MRTX option volume was 5X normal on Friday with 7,607 contracts. Call volume was 72% and put volume was 28%. https://t.co/H37dBxgfzQ
October 20th 2019, 11:10am
dailypoliticaln @dailypoliticaln
Mirati Therapeutics $MRTX Upgraded at BidaskClub https://t.co/VUnr9sLd4C
October 20th 2019, 7:10am
ZolmaxNews @ZolmaxNews
Mirati Therapeutics $MRTX Upgraded by BidaskClub to “Hold” https://t.co/d6RaEaxA1J
October 20th 2019, 7:10am
TranscriptDaily @TranscriptDaily
Mirati Therapeutics $MRTX Stock Rating Lowered by Zacks Investment Research https://t.co/UNgjGzcN0D
October 20th 2019, 1:10am
gcassidy718 @gcassidy718
$MRTX major movements -12.29 % change recently https://t.co/yyGCIG9Q8V
October 19th 2019, 3:10pm
bbnsnews @bbnsnews
Mirati Therapeutics $MRTX Cut to Sell at Zacks Investment Research https://t.co/WzTX37KBQn
October 19th 2019, 1:10pm
ThisLincolnian @ThisLincolnian
Mirati Therapeutics $MRTX Lifted to “Hold” at BidaskClub https://t.co/IxfRzMaMVK
October 19th 2019, 1:10pm
WeekHerald @WeekHerald
Mirati Therapeutics $MRTX Cut to Sell at Zacks Investment Research https://t.co/iJtN76UJB1
October 19th 2019, 1:10pm
SPX219 @SPX219
$mrtx why did $mrtx fall after analysts spoke with management if data is still not yet released?
October 19th 2019, 12:10pm
ThisLincolnian @ThisLincolnian
HC Wainwright Reiterates “Buy” Rating for Mirati Therapeutics $MRTX https://t.co/UiHtfDjGws
October 19th 2019, 10:10am
dailypoliticaln @dailypoliticaln
Mirati Therapeutics $MRTX Shares Up 8.3% https://t.co/CGQSdDPYcP
October 19th 2019, 10:10am
stb8444 @stb8444
i was scared of shorting $mrtx at $110 but it obviously seemed overvalued at the time. everything is easy in hindsi… https://t.co/NYqHOQRIK2
October 19th 2019, 1:10am
ThisLincolnian @ThisLincolnian
Stock Traders Buy Large Volume of Mirati Therapeutics Call Options $MRTX https://t.co/OtXMheGdNY
October 19th 2019, 1:10am
WeekHerald @WeekHerald
Stock Traders Buy Large Volume of Mirati Therapeutics Call Options $MRTX https://t.co/2i1yXkBAYF
October 19th 2019, 1:10am
tomorrowdaworld @tomorrowdaworld
RT @adamfeuerstein: My tweet may have been too cryptic, sorry. With apparent stage-managing from $MRTX, analysts are both 1) walking back h…
October 18th 2019, 7:10pm
jsrosenblum @jsrosenblum
RT @bradloncar: $MRTX meets with every sell side analyst on the street yesterday and today it's the worst performing stock in biotech. Good…
October 18th 2019, 6:10pm
dailypoliticaln @dailypoliticaln
Mirati Therapeutics’ $MRTX Buy Rating Reaffirmed at HC Wainwright https://t.co/Cl5Yed6ZlY
October 18th 2019, 6:10pm
ZolmaxNews @ZolmaxNews
Mirati Therapeutics $MRTX Stock Rating Reaffirmed by HC Wainwright https://t.co/H2IwOSSU4c
October 18th 2019, 6:10pm
bradloncar @bradloncar
$MRTX meets with every sell side analyst on the street yesterday and today it's the worst performing stock in biote… https://t.co/eLDwZfmddt
October 18th 2019, 4:10pm
JMac_SI @JMac_SI
$MRTX chart looking a bit like a boa constrictor ate an elephant the past few days... https://t.co/PBpFmIzVzA
October 18th 2019, 4:10pm
NedPagliarulo @NedPagliarulo
Wondering how much $MRTX might trade up/down when it presents KRAS data ~10 days from now? Raymond James pulled nu… https://t.co/60nwEqEE7Z
October 18th 2019, 3:10pm
dakotafinancial @dakotafinancial
Mirati Therapeutics Inc $MRTX Receives $104.36 Average Target Price from Analysts https://t.co/zteXxoD721
October 18th 2019, 2:10pm
BlueBioNow @BlueBioNow
$MRTX I’ll probably buy on the dip. Still need to do more research. -11.38 % https://t.co/JVIY1gHvbg
October 18th 2019, 1:10pm
BioPharmaDive @BioPharmaDive
$MRTX soared this year, driven higher by optimism the drugmaker can replicate Amgen's KRAS success. Data due Oct. 2… https://t.co/C09ZFTimPt
October 18th 2019, 1:10pm
BayAreaBiotechI @BayAreaBiotechI
Biotwitter, any guesses on what happened here? $MRTX https://t.co/EAQ5MtAhfz
October 18th 2019, 1:10pm
tatianadariee @tatianadariee
Timely piece from my colleague @CristinNara ahead of $MRTX's data next week: https://t.co/a43TvS2CPj
October 18th 2019, 12:10pm
QuantchaIdeas @QuantchaIdeas
Big Loser Alert: Trading today’s -9.9% move in MIRATI THERAPEUTICS INC. COMM $MRTX https://t.co/NUHGU2sD0C https://t.co/gprJ5x6VGT
October 18th 2019, 10:10am
adamfeuerstein @adamfeuerstein
My tweet may have been too cryptic, sorry. With apparent stage-managing from $MRTX, analysts are both 1) walking ba… https://t.co/ZznkLJaTOA
October 18th 2019, 10:10am
stocknewstimes @stocknewstimes
Mirati Therapeutics $MRTX Stock Rating Upgraded by BidaskClub https://t.co/N5Z52cpI2a
October 18th 2019, 9:10am
registrarjourn @registrarjourn
Mirati Therapeutics $MRTX Upgraded to “Hold” by BidaskClub https://t.co/S3I5JrGJbr
October 18th 2019, 8:10am
EnterpriseLeade @EnterpriseLeade
Mirati Therapeutics $MRTX Upgraded to “Hold” by BidaskClub https://t.co/eYbdDbG7aC
October 18th 2019, 8:10am
stocknewstimes @stocknewstimes
Mirati Therapeutics Target of Unusually High Options Trading $MRTX https://t.co/ApX77sZ5Na
October 18th 2019, 8:10am
TheMarketsDaily @TheMarketsDaily
Mirati Therapeutics Target of Unusually High Options Trading $MRTX https://t.co/1btG4oAuFp
October 18th 2019, 8:10am
hubertus1964 @hubertus1964
RT @adamfeuerstein: How to express in gif form the feeling of reading the sell-side notes on $MRTX after all the analysts have spoken to ma…
October 18th 2019, 7:10am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.